Thanks to Reviewers.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 220, doi. 10.1177/09612033251314644
- Publication type:
- Article
Works matching IS 09612033 AND DT 2025 AND VI 34 AND IP 2
Results: 13
1
2
Proportion, domains, and risk factors of cognitive impairment in systemic lupus erythematosus.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 157, doi. 10.1177/09612033251314592
- By:
- Publication type:
- Article
3
Disease features at diagnosis and changes in disease course severity among commercially insured patients with childhood-onset compared with adult-onset systemic lupus erythematosus.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 167, doi. 10.1177/09612033251314589
- By:
- Publication type:
- Article
4
Investigating how patients with lupus nephritis access and trust health information: Results from a Canadian survey of patients with lupus nephritis.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 217, doi. 10.1177/09612033251313578
- By:
- Publication type:
- Article
5
Urinary congophilia as a predictive biomarker of lupus nephritis in pregnant and non-pregnant women with systemic lupus erythematosus.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 149, doi. 10.1177/09612033241312746
- By:
- Publication type:
- Article
6
Systemic lupus erythematosus is a risk factor for having multiple subtypes of cutaneous lupus erythematosus.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 181, doi. 10.1177/09612033241311335
- By:
- Publication type:
- Article
7
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 133, doi. 10.1177/09612033241311330
- By:
- Publication type:
- Article
8
Utilisation patterns of immunomodulators and pregnancy outcomes in systemic lupus erythematosus: Insights from Korean national data.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 140, doi. 10.1177/09612033241310087
- By:
- Publication type:
- Article
9
2019 EULAR/ACR classification criteria for SLE score predicts future lupus hospital admission and costs.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 178, doi. 10.1177/09612033241310071
- By:
- Publication type:
- Article
10
Lupus and SARS-CoV-2: What have we learned after the pandemic?
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
11
Telitacicept for refractory cystitis associated with severe systemic lupus erythematosus: A case report.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
12
Serious infections and tuberculosis adversely impact outcomes of juvenile onset systemic lupus erythematosus in India.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 193, doi. 10.1177/09612033241309510
- By:
- Publication type:
- Article
13
Healthcare costs of systemic lupus erythematosus in New Zealand.
- Published in:
- Lupus, 2025, v. 34, n. 2, p. 204, doi. 10.1177/09612033241308109
- By:
- Publication type:
- Article